Notified Body designation and scope, the impact of Brexit and Competent Authority and Notified Body interpretation of the regulations. Make sure you are up to date!

Article 117: Preparing Drug Device Combination Product Manufacturers for the EU MDR - WHITEPAPER

ArticleImage

Download the exclusive whitepaper

The EMA has seen an increase in the number of scientific advice requests and Marketing Authorisation Applications for devices  where a medicinal product incorporates, either in an integral or non-integral manner, a medical device component.

Previously, there were no clear regulatory requirements for such types of medical devices,  but Article 117 of the EU MDR has provided an amendment outlining specific requirements for drug device combination medical products.

This whitepaper offers advice to prepare drug device combination product manufacturers for the new regulations, including:

  • Seeking  Notified Body opinion

  • Products covered

  • Marketing Authorization applications

  • General Safety and Performance Requirements (GSPRs)


To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.